318 related articles for article (PubMed ID: 34579778)
1. Novel multivalent design of a monoclonal antibody improves binding strength to soluble aggregates of amyloid beta.
Rofo F; Buijs J; Falk R; Honek K; Lannfelt L; Lilja AM; Metzendorf NG; Gustavsson T; Sehlin D; Söderberg L; Hultqvist G
Transl Neurodegener; 2021 Sep; 10(1):38. PubMed ID: 34579778
[TBL] [Abstract][Full Text] [Related]
2. The murine version of BAN2401 (mAb158) selectively reduces amyloid-β protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice.
Tucker S; Möller C; Tegerstedt K; Lord A; Laudon H; Sjödahl J; Söderberg L; Spens E; Sahlin C; Waara ER; Satlin A; Gellerfors P; Osswald G; Lannfelt L
J Alzheimers Dis; 2015; 43(2):575-88. PubMed ID: 25096615
[TBL] [Abstract][Full Text] [Related]
3. A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer's Disease Mice.
Rofo F; Meier SR; Metzendorf NG; Morrison JI; Petrovic A; Syvänen S; Sehlin D; Hultqvist G
Neurotherapeutics; 2022 Sep; 19(5):1588-1602. PubMed ID: 35939261
[TBL] [Abstract][Full Text] [Related]
4. Efficient clearance of Aβ protofibrils in AβPP-transgenic mice treated with a brain-penetrating bifunctional antibody.
Syvänen S; Hultqvist G; Gustavsson T; Gumucio A; Laudon H; Söderberg L; Ingelsson M; Lannfelt L; Sehlin D
Alzheimers Res Ther; 2018 May; 10(1):49. PubMed ID: 29793530
[TBL] [Abstract][Full Text] [Related]
5. Lecanemab, Aducanumab, and Gantenerumab - Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease.
Söderberg L; Johannesson M; Nygren P; Laudon H; Eriksson F; Osswald G; Möller C; Lannfelt L
Neurotherapeutics; 2023 Jan; 20(1):195-206. PubMed ID: 36253511
[TBL] [Abstract][Full Text] [Related]
6. A light at the end of the tunnel - from mutation identification to a potential treatment for Alzheimer's disease.
Lannfelt L
Ups J Med Sci; 2023; 128():. PubMed ID: 38084203
[TBL] [Abstract][Full Text] [Related]
7. The conformational epitope for a new Aβ42 protofibril-selective antibody partially overlaps with the peptide N-terminal region.
Colvin BA; Rogers VA; Kulas JA; Ridgway EA; Amtashar FS; Combs CK; Nichols MR
J Neurochem; 2017 Dec; 143(6):736-749. PubMed ID: 28881033
[TBL] [Abstract][Full Text] [Related]
8. Lecanemab demonstrates highly selective binding to Aβ protofibrils isolated from Alzheimer's disease brains.
Johannesson M; Söderberg L; Zachrisson O; Fritz N; Kylefjord H; Gkanatsiou E; Button E; Svensson AS; Rachalski A; Nygren P; Osswald G; Lannfelt L; Möller C
Mol Cell Neurosci; 2024 Jun; 130():103949. PubMed ID: 38906341
[TBL] [Abstract][Full Text] [Related]
9. Large aggregates are the major soluble Aβ species in AD brain fractionated with density gradient ultracentrifugation.
Sehlin D; Englund H; Simu B; Karlsson M; Ingelsson M; Nikolajeff F; Lannfelt L; Pettersson FE
PLoS One; 2012; 7(2):e32014. PubMed ID: 22355408
[TBL] [Abstract][Full Text] [Related]
10. An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease.
Lord A; Gumucio A; Englund H; Sehlin D; Sundquist VS; Söderberg L; Möller C; Gellerfors P; Lannfelt L; Pettersson FE; Nilsson LN
Neurobiol Dis; 2009 Dec; 36(3):425-34. PubMed ID: 19703562
[TBL] [Abstract][Full Text] [Related]
11. A new class of monoclonal Aβ antibodies selectively targets and triggers deposition of Aβ protofibrils.
Grover S; Pham T; Jones A; Sinobas-Pereira C; Villoch Diaz Maurino M; Garrad EC; Makoni NJ; Parks A; Domalewski RJ; Riggio G; An H; Chen K; Nichols MR
J Neurochem; 2023 Jun; 165(6):860-873. PubMed ID: 37002186
[TBL] [Abstract][Full Text] [Related]
12. Sensitive detection of Aβ protofibrils by proximity ligation--relevance for Alzheimer's disease.
Kamali-Moghaddam M; Pettersson FE; Wu D; Englund H; Darmanis S; Lord A; Tavoosidana G; Sehlin D; Gustafsdottir S; Nilsson LN; Lannfelt L; Landegren U
BMC Neurosci; 2010 Oct; 11():124. PubMed ID: 20923550
[TBL] [Abstract][Full Text] [Related]
13. Disease modifying effects of the amyloid-beta protofibril-selective antibody mAb158 in aged Tg2576 transgenic mice.
Rizoska B; Zachrisson O; Appelkvist P; Boström E; Björklund M; Rachalski A; Gkanatsiou E; Kylefjord H; Söderberg L; Nygren P; Eriksson F; Ishikawa Y; Fukushima T; Koyama A; Osswald G; Lannfelt L; Möller C
Mol Cell Neurosci; 2024 Jun; 130():103950. PubMed ID: 38901655
[TBL] [Abstract][Full Text] [Related]
14. A possible mechanism for the enhanced toxicity of beta-amyloid protofibrils in Alzheimer's disease.
Chen ZL; Singh PK; Calvano M; Norris EH; Strickland S
Proc Natl Acad Sci U S A; 2023 Sep; 120(36):e2309389120. PubMed ID: 37639602
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
Swanson CJ; Zhang Y; Dhadda S; Wang J; Kaplow J; Lai RYK; Lannfelt L; Bradley H; Rabe M; Koyama A; Reyderman L; Berry DA; Berry S; Gordon R; Kramer LD; Cummings JL
Alzheimers Res Ther; 2021 Apr; 13(1):80. PubMed ID: 33865446
[TBL] [Abstract][Full Text] [Related]
16. Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer's disease.
Lannfelt L; Möller C; Basun H; Osswald G; Sehlin D; Satlin A; Logovinsky V; Gellerfors P
Alzheimers Res Ther; 2014; 6(2):16. PubMed ID: 25031633
[TBL] [Abstract][Full Text] [Related]
17. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
[TBL] [Abstract][Full Text] [Related]
18. The Aβ protofibril selective antibody mAb158 prevents accumulation of Aβ in astrocytes and rescues neurons from Aβ-induced cell death.
Söllvander S; Nikitidou E; Gallasch L; Zyśk M; Söderberg L; Sehlin D; Lannfelt L; Erlandsson A
J Neuroinflammation; 2018 Mar; 15(1):98. PubMed ID: 29592816
[TBL] [Abstract][Full Text] [Related]
19. Specific uptake of an amyloid-β protofibril-binding antibody-tracer in AβPP transgenic mouse brain.
Magnusson K; Sehlin D; Syvänen S; Svedberg MM; Philipson O; Söderberg L; Tegerstedt K; Holmquist M; Gellerfors P; Tolmachev V; Antoni G; Lannfelt L; Hall H; Nilsson LN
J Alzheimers Dis; 2013; 37(1):29-40. PubMed ID: 23780660
[TBL] [Abstract][Full Text] [Related]
20. Sensitive ELISA detection of amyloid-beta protofibrils in biological samples.
Englund H; Sehlin D; Johansson AS; Nilsson LN; Gellerfors P; Paulie S; Lannfelt L; Pettersson FE
J Neurochem; 2007 Oct; 103(1):334-45. PubMed ID: 17623042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
